Electromed (ELMD) Operating Income Growth (3y) (2013 - 2026)
Electromed (ELMD) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 34.83% |
| 10 | Electromed | 321.10 Mn | 304.11 Mn | 14.64 Mn | 46.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.57% |
| Dec 31, 2025 | 41.64% |
| Sep 30, 2025 | 292.96% |
| Jun 30, 2025 | 83.13% |
| Mar 31, 2025 | 35.35% |
| Dec 31, 2024 | 33.18% |
| Sep 30, 2024 | 53.29% |
| Jun 30, 2024 | 53.00% |
| Mar 31, 2024 | 96.40% |
| Dec 31, 2023 | 12.65% |
| Sep 30, 2023 | -40.17% |
| Jun 30, 2023 | 5.03% |
| Mar 31, 2023 | 9.41% |
| Dec 31, 2022 | -6.67% |
| Sep 30, 2022 | -68.05% |
| Jun 30, 2022 | -30.72% |
| Mar 31, 2022 | 22.93% |
| Dec 31, 2021 | 16.82% |
| Sep 30, 2021 | 38.68% |
| Jun 30, 2021 | -19.82% |